Primary angle-closure glaucoma (PACG) is a common cause of blindness. Angle closure is a fundamental pathologic process in PAGC. With the development of imaging devices for the anterior segment of the eye, a better understanding of the pathogenesis of angle closure has been reached. Aside from pupillary block and plateau iris, multiple-mechanisms are more common contributors for closure of the angle such as choroidal thickness and uveal expansion, which may be responsible for the presenting features of PACG. Recent Genome Wide Association Studies identified several new PACG loci and genes, which may shed light on the molecular mechanisms of PACG. The current classification systems of PACG remain controversial. Focusing the anterior chamber angle is a principal management strategy for PACG. Treatments to open the angle or halt the angle closure process such as laser peripheral iridotomy and/or iridoplasty, as well as cataract extraction, are proving their effectiveness. PACG may be preventable in the early stages if future research can identify which kind of angles and/or persons are more likely to benefit from prophylactic treatment. New treatment strategies like adjusting the psychological status and balancing the sympathetic-parasympathetic nerve activity, and innovative medicines are needed to improve the prognosis of PACG.
Introduction
Glaucoma is the leading cause of irreversible blindness worldwide. It is estimated that bilateral blindness was present in 4.5 million people with primary open angle glaucoma (POAG) and 3.9 million people with primary angle closure glaucoma (PACG) in 2010, rising to 5.9 million and 5.3 million people in 2020. Compared with the rates of blindness in POAG, population based studies show that PACG on average carries a three-fold increased risk of severe, bilateral visual impairment (Quigley and Broman, 2006; Friedman et al., 2012; Tham et al., 2014) .
Our understanding of PACG has been considerably improved in the last two decades as the harmfulness of the disease is better recognized worldwide. With regard to the clinical course and pathogenic mechanisms, PACG is a different kind of glaucoma compared with POAG. Angle closure is the primary fundamental problem in PACG, while elevated intraocular pressure (IOP) is secondary to angle closure. To some extent, PACG is a preventable disease if the angle closure process can be halted in the early stages. Treatments to open the angle such as laser peripheral iridotomy (LPI) and/or iridoplasty, as well as cataract extraction, are proving their effectiveness. However, there is still huge gap between current knowledge and clinical management of PACG.
Nomenclature
PACG is characterized by elevated intraocular pressure (IOP) as a result of mechanical obstruction of the trabecular meshwork by either apposition of the peripheral iris to the trabecular meshwork or by a synechial closed angle (Yanoff and Duker, 2014) . It can be classified in different ways, based on clinical presentation, natural history, anatomy and etiology, etc. Each classification has its advantages and value in practice. Currently, however, we still need to work out a comprehensive and widely-accepted classification system for both clinical and research purposes.
Clinical classification
A classical classification of PACG is based on clinical presentation. PACG can be classified according to the timing or suddenness of onset into acute PACG or chronic PACG. The clinical course of acute PACG can be further divided into preclinical, attack (including acute, subacute or intermediate attacks), intermittent, chronic progression, and absolute stages according to the symptom and signs (Ji et al., 1966; Salmon, 1993) . In the acute attack stage of PACG, the iris quickly and completely covers the entire trabecular meshwork, leading to a sudden, symptomatic elevation of IOP. If it does not remit spontaneously or under medical intervention, it will enter the chronic stage. In subacute attack, the symptoms are less severe and the IOP may recover spontaneously.
By contrast, in chronic PACG, the iris slowly covers the trabecular meshwork portion by portion, leading to peripheral anterior synechiae (PAS). The PAS may be discrete or multi-centered at the beginning, then gradually expand and fuse together (Sun et al., 1994; Wright et al., 2016) (Fig. 1) . The IOP is gradually elevated over a long period of time. This process is often painless and asymptomatic because the eyes have enough time to accommodate to the elevated IOP.
This classification is clear to understand and useful in helping clinicians choose an appropriate treatment for different clinical presenting cases. However, the clinical presentation of acute and chronic PACG may sometimes overlap, which makes diagnosis more challenging. Unlike POAG, PACG does not require glaucomatous optic nerve damage in this definition.
Epidemiological classification
Since POAG is defined as an acquired optic neuropathy associated with characteristic structural damage to the optic nerve and visual field loss, the difference in the definition of PACG and POAG makes it difficult to compare prevalence and study risk factors in epidemiological glaucoma research. Hence, the International Society of Geographic and Epidemiologic Ophthalmology (ISGEO) developed a scheme for diagnosis of glaucoma in 2002 . Since then, it has gradually become a standard definition of PACG in population based epidemiological studies. In this scheme, 3 categories were classified: (1) Primary angle closure suspect (PACS): an eye in which appositional contact between the peripheral iris and posterior trabecular meshwork is considered possible. (2) Primary angle closure (PAC): an eye with an occludable angle and features indicating that trabecular obstruction by the peripheral iris has occurred. The optic disc does not have glaucomatous damage. (3) PACG: PAC together with evidence of glaucomatous optic neuropathy. Therefore, it is a continuum from PACS, to PAC, to PACG, according to the ISGEO protocol of primary angle closure diseases.
Many population-based surveys have adopted the ISGEO classification. In practice, a key issue is the definition of occludable angle, which is considered as a diagnostic threshold. It was initially defined as !270 of the posterior (usually pigmented) trabecular meshwork not seen on gonioscopy, in keeping with several population studies (Arkell et al., 1987; Salmon et al., 1993; Foster et al., 1996 Foster et al., , 2000 . Later studies have shown that it is too stringent as at least half of those who had PAS and glaucomatous optic neuropathy were excluded from being defined as PACG . Then, 180 degree of posterior trabecular meshwork not seen on gonioscopy in primary gaze without indentation, or simply 180 or more iridotrabecular contact (ITC), has been widely accepted (Thomas et al., 2003a,b; Shen et al., 2008; Liang et al., 2011) . However, there is still debate that this slightly more liberal threshold is still likely to exclude many people who have primary PAS or appositional angle closure (Foster et al., , 2006 .
Glaucomatous optic neuropathy has been defined in this scheme using three levels of evidence. The highest level of certainty requires optic disc abnormalities (CDR or CDR asymmetry >97.5th percentile for the normal population, or a neuroretinal rim width reduced to <0.1 CDR between 11 and 1 o'clock or 5 to 7 o'clock) and visual field defect compatible with glaucoma. It also makes provision for some eyes in which visual field testing or disc evaluation are not possible. In the second level of evidence, if the subject could not satisfactorily complete visual field testing but had a CDR or CDR asymmetry >99.5th percentile for the normal population, glaucoma was diagnosed solely on the structural evidence. Lastly, if the optic disc could not be examined because of media opacity (and hence, a field test was also not possible), an IOP exceeding the 99.5th percentile of the normal population, or evidence of previous glaucoma filtering surgery, may be taken as sufficient for a diagnosis of glaucoma. The 97.5th percentile for vertical CDR has been proposed as a useful tool to assist in the diagnosis of glaucoma in population studies. In practice, vertical CDR ¼ 0.7 has been reported to be the 97.5th percentile value of the study population in many epidemiological studies. However, this criterion is nonspecific in the diagnosis of PACG. Liang et al. reported in the Handan Eye Study (HES) with 5480 subjects in a rural Chinese population that four (4/32) cases of PACG identified by the HES expert group did not meet the ISGEO definition for glaucoma because the cup/ disc ratio was not greater than 0.7; and 23 (23/51) cases that met the ISGEO definition of PACG were not found to have glaucoma using the HES consensus process (Liang et al., 2011) . A schematic drawing and representative gonioscopic images to show the different shapes of PAS and angle closure in chronic PACG. Most grading systems that are used clinically appear to simply judge approximate angle opening in degrees or in Grades 1e4 in four cardinal positions which gives limited information. The use of a schematic diagram with essentially three concentric rings describing Schwalbe's line, scleral spur and iris insertion with the contact between iris and corneoscleral junction in the black hash line giving a nice descriptive record of the state of the angle. It may also include a description of the iris configuration, i.e. whether there is bombe present, a straight insertion, a plateau iris or a concave iris.
Pathogenic classification
One of the deficiencies with the above classification systems is that they do not identify the mechanism responsible for angle closure. The classification, devised by Ritch and colleagues, is based on anatomic levels of obstruction to aqueous flow in primary and secondary angle closure glaucoma (ACG) (Ritch and Lowe, 1996) . In their scheme, angle closure in ACG may be due to forces acting at four anatomic levels: Level I, the iris, including pupillary block, nonpupillary block/angle crowding mechanisms, and contraction of fibrin in angle secondary to other ocular diseases, etc. Level II, the ciliary body, including plateau iris configuration and iridociliary cysts. Level III, the lens, including thick, anteriorly positioned and subluxed lens. Level IV, vectors posterior to the lens, including aqueous misdirection, choroidal effusion, and space-occupying lesions etc. However, in many ACG patients multiple "levels" may simultaneously or consecutively play a role. To mix primary and secondary ACG into one classification system also makes it confusing in the diagnosis and treatment. Recently, Ng and colleagues suggested that in view of angle closure can recur following peripheral iridotomy in up to 58% of cases, the mechanism of angle closure could be classified into pupillary block, plateau iris syndrome, lens disproportion, and ciliary block (Ng et al., 2012) . Further studies are needed to test whether combining the classical classification of PACG with concise pathogenic subgrouping is feasible in clinical practice.
With the development of imaging devices for the anterior segment of the eye, some causes of angle closure, such as lens subluxation, spherical lens, and ciliary cysts could be detected and differentiated from conventional PACG. The definition and classification of PACG may become more concise as we get to know more about the pathogenesis of angle occlusion.
Epidemiology
With the world's population aging, glaucoma prevalence and morbidity can be expected to increase. As a potentially preventable disease, epidemiological studies on PACG are especially warranted. It is estimated that the number of people aged 40e80 years with PACG worldwide was 20.17 million in 2013, and predicted to increase to 23.36 million in 2020 and 32.04 million in 2040. Asia accounts for about 77% of worldwide PACG cases . Advancing age and female gender are two major predisposing factors for the development of PACG (Foster et al., 1996 (Foster et al., , 2000 Yamamoto et al., 2005; He et al., 2006a,b; Liang et al., 2011) .
Prevalence
The prevalence of PACG varies across geographic regions and ethnic groups. In the past 15 years, there has been a rapid emergence of more than 20 population-based prevalence studies on glaucoma, particularly from Asia. Two studies in African and Latin American regions provide first-hand epidemiologic data on PACG in these regions (Budenz et al., 2013; Sakata et al., 2007) . According to a recent analysis , the prevalence of PACG is highest in Asia (1.09%). This result is consistent with previous PACG reviews (Quigley and Broman, 2006) . The prevalence of PACG in Latin America and the Caribbean (0.85%) and Africa (0.60%) is higher than those in Europe (0.42%) and North America (0.26%).
In most population based studies, POAG is the most common type of glaucoma. However, the higher prevalence of PACG among Eskimos, Chinese and Mongolians has long been acknowledged. In 1971, Clemmesen and Alsbirk reported high rates of PACG in Greenlandic Inuit (Clemmesen and Alsbirk, 1971 ). Since then, several studies have shown that PACG prevalence in Eskimos (also called Inuit, who are anthropologically linked to the SinoMongolian people) is about 20e40 times higher than among Caucasians (Arkell et al., 1987; Alsbirk, 1992) . Recently, two studies from Northeast Asia, Hovsgol, Mongolia (1.4% vs. 0.5%) and Harbin, China (1.6% vs. 0.7%), have shown that the prevalence of PACG is higher than that of POAG, further suggesting that Sino-Mongolian people are more susceptible to PACG than POAG (Foster et al., 1996; Qu et al., 2011) . From an evolutionary perspective on SinoMongolian people, it is postulated that shallow anterior chambers may have evolved as an anatomical adaptation to resist corneal freezing in northeast Asia during the last Ice Age (Casson, 2008) .
Among all the Asian epidemiologic studies, the Meiktila Eye Study in Myanmar, South Asia, reported the highest prevalence of PACG (2.5%) (Casson et al., 2007) . The prevalence of POAG was also relatively high (2.0%) in this study. The Singapore Malay Eye Study reported the lowest prevalence (0.12%) of PACG in the Malay population of Singapore, Southeast Asia, while 1.1% of Chinese Singaporeans had PACG (Shen et al., 2008) .
Recently, a systemic review showed that of those over 40 years old in European derived populations, 0.4% are estimated to have PACG (Day et al., 2012) . As a first glaucoma prevalence study in Latin America, PACG prevalence was reported to be 0.7% in the southern region of Brazil (Sakata et al., 2007) . Both are higher than previous estimates (0.1%e0.25%) (Congdon et al., 1992; Quigley and Broman, 2006) . Further studies are needed to address the roles of genetics and epigenetic changes in the prevalence of PACG in different geographic regions and ethnic groups.
On the other hand, hospital based studies from China as well as other Asian countries showed that PACG is the most common type of glaucoma in a particular hospital/clinic, though the proportion of POAG is rising. The clinical data from our hospital reveals that PACG accounted for 50e55%, while POAG accounted for 25e35% of all glaucoma patients (approximately 60,000 visits/year) in our outpatient department in the past 5 years (unpublished data). However, hospital-based studies are subject to the bias that acute ACG is more likely to cause symptoms than POAG. Those patients are therefore more likely to seek medical assistance, so the hospital based studies may tend to overestimate the incidence of PACG. Meanwhile, for ophthalmologists who are practicing in PACG highrisk areas, it is important to be competent in handling emergency cases of PACG attack.
Incidence
The prevalence of disease represents the frequency of existing cases in a defined population at a given point of time, while incidence is the rate of occurrence of new cases arising in a specified population in a given period (Bonita et al., 2006) . Longitudinal incidence studies are helpful to understand the natural history and the causes of the disease. However, data on the incidence rate of PACG are limited.
In respect of the natural history of PACS progressing to PACG, Alsbirk et al. reported that among a high risk cohort of Greenland Eskimos (shallow chamber at the limbus), 8% of normal (angles open on gonioscopy) and 35% of PACS progressed to PAC or PACG over 10 years (Alsbirk, 1992) . Recently, Thomas et al. reported that 22% of PACS progressed to PAC over 5 years in a population based study from south India (Thomas et al., 2003a,b) , and 28.5% of PAC progressed to PACG during the same period (Thomas et al., 2003a,b) . Yip et al. reported that the 6-year incidence of occludable angles (PACS) in a high risk Mongolian population (central anterior chamber depth <2.53 mm) was 20.4%. Narrower angle was identified as the main risk factor for progression of PACG (Yip et al., 2008) .
What we want to know
PACG carries a heavier burden of visual morbidity than POAG . Screening and prophylactic treatment of PACS and PAC may form a feasible population-level intervention. However, less than 35% cases developed PAC or PACG after 5e10 years' follow-up. Why do most cases not develop PAC or PACG without any intervention? Taking into account cost-effective management, more information about the PACG incidence with the adoption of prophylactic interventions is required before population-based intervention approach could be considered. Randomized controlled clinical trials are needed not only to assess the long-term efficacy of treatments to open the angle, but also to explore factors associated with a low risk of progressing to angle closure or angle closure glaucoma in this high risk population. As we move forward in the big data age, big data analysis may bring new approaches to better recognize the epidemiology of PACG.
Pathogenesis
PACG has its characteristic anatomy features and unique pathological process, which makes it completely different from POAG. A crowded anterior segment and narrow anterior chamber angle are the basic anatomic features for PACG. The progression that the anterior chamber angle develops from narrow to become closed is quite complicated and involves many different factors (Fig. 2) . With the development of imaging devices for the anterior segment, better understanding of the pathogenesis of angle closure has been reached. However, there are still many questions remaining to be answered.
Anatomical risk factors
PACG eyes usually have the following anatomical features: small cornea, shallow anterior chamber, thick lens, anterior lens position, and short axial length (AL) (Lowe, 1970; Lee et al., 1984; Marchini et al., 1998) . However, some angle closures are not fully explained by these anatomical risk factors. With the increasing use of new anterior chamber assessment techniques such as ultrasound biomicroscopy (UBM) and OCT, anterior segment parameters can be precisely measured. Quantitative measurements revealed that the position of the ciliary processes is another one of the most important differences between patient's angle closure eyes and normal eyes (Fig. 3) . The ciliary processes are rotated more anteriorly in patients with PACG (Marchini et al., 1998) . The trabecular to ciliary process distance (TCPD), which is the length of a line perpendicular to the iris connecting a point on the trabecular meshwork 500 mm from the scleral spur to the ciliary process, seems a useful measure of ciliary body rotation and relative ciliary block (Man et al., 2015) . Greater iris curvature, larger iris volume and a thicker iris are independently associated with narrow angles as well . Iris thickness was shown to be likely to play a role in the development of angle closure and ultimately PACG . Smaller ACA (anterior chamber area) and ACV (anterior chamber volume) were independently associated with the presence of narrow angles, even after controlling for other known ocular biometric parameters, such as anterior chamber depth (ACD) and AL (Wu et al., 2011) . Anterior chamber width (ACW), which was defined as the horizontal scleral spur-to-spur distance, could be a novel risk indicator for angle closure. Nongpiur et al. found ACW was associated with narrow angle, independently of age, gender and AL, in two different studies of Singapore populations (Nongpiur et al., 2010) . ACV was calculated to be 25% lower in PACG patients than normal people (Congdon et al., 1997) . These fundamental anatomical characteristics of PACG are partially because the position or the size of lens is out of proportion to the eyeball (Lowe, 1970; Phillips, 1972) . The lens is thought be play a crucial role in the pathogenesis of angle closure disease either because of an increase in its thickness or a more anterior position resulting in angle crowding and a greater predisposition to pupillary block (Marchini et al., 1998; . Lens vault (LV), defined as the perpendicular distance between the anterior pole of the crystalline lens and a horizontal line joining the 2 scleral spurs, was described independent ocular parameter associated with angle closure. For the purpose of screening, LV has better performance than other various parameters of lens, such as lens position, (LP, defined as ACDþ1/2 lens thickness (LT)), relative lens position (defined as LP/AL), and LT-to-AL ratio, and even better than ACD and AL . The thickness of lens increases with age and makes the narrow anterior chamber angle even more crowded, which might be a reasonable explanation for why most PACG happens in patients older than 40 years. 
Important parameters relevant to PACG
The eye is an optical organ with a unique arrangement of optical media and blood supply. It is important to appreciate some anatomic and physiological parameters which are highly relevant to understanding the pathogenesis of PACG. Fig. 4 schematically illustrates and estimates some of these critical parameters.
The cornea and the sclera are dense connective tissues designed to provide structural integrity of the globe and to protect the inner components of the eye from physical injury. The ocular rigidity is of the order of 0.77 mmHg/ml meaning tiny changes in intraocular volume could induce significant increase in IOP (Collins and Van der Werff, 1980) . The cornea covers the anterior 1/6th of the total surface area of the globe, while the sclera covers the remaining 5/ 6 ths (Kaufman and Alm, 2003) . The volume of the anterior chamber and posterior chamber are approximately 250 ml and 60 ml respectively which are a relatively small fraction of the total intraocular volume (6000 ml) (Collins and Van der Werff, 1980) . The iris is the anterior portion of the uvea forming a delicate and movable diaphragm between the anterior and posterior chambers (Hogan et al., 1971) . The lens is suspended in the anterior of the eye by a band of inelastic microfibrils, the zonules. To meet the high demands of neural retina and avascular tissues in the anterior segments such as lens and cornea, the ocular circulation is unique and complex with high intraocular blood flow rate (~850 ml/min).
The uvea, including the iris and ciliary body has a rich blood vasculature and uveal blood pressure (systolic~75 mmHg and diastolic~35 mmHg) is higher than normal IOP (~15 mmHg).
Aqueous outflow rate is about 2 ml per minute. Intraocular contents such as aqueous humor, vitreous and tissues are relatively incompressible and are bounded by the relatively rigid cornea and sclera. Therefore, input and output fluid including aqueous and blood have to be dynamical balanced in order to maintain IOP in the normal range. Such delicate balance can be disturbed by pathological changes in the iris and choroid as pathogenic factors of PACG.
Mechanism of angle closure
The anterior chamber angle closes due to two types of forces: the forces that push the iris forward and the forces that pull the iris against the trabecular meshwork. Thus, the classical mechanisms of PACG could be mainly divided to two types: pupillary block and non-pupillary block. Pupillary block is the main common known mechanism of PAC. It mainly due to the proximity between the lens and the posterior face of the iris generates an increase in aqueous flow resistance, thus generates the pressure difference between the posterior chamber and anterior chamber and force the peripheral iris to bow anteriorly (Tarongoy et al., 2009; Quigley et al., 2003) . Non pupillary block factors include thick peripheral iris, anteriorly located peripheral iris, anteriorly rotated ciliary body and plateau iris. About half of the PACG in Chinese patients (54.8%) was caused by multiple mechanisms, one third (38.1%) was caused by pure pupillary block and less than 10% (7.1%) was caused by pure nonpupillary block mechanisms (Wang et al., 2000) . Plateau iris was defined by anteriorly directed ciliary body, absent ciliary sulcus, steep iris root from its point of insertion followed by a downward angulation, flat iris plane and irido-angle contract (Kumar et al., 2009 ). Plateau iris is found in about one third of Asian PACG eyes with a patent LPI (Kumar et al., 2008 (Kumar et al., , 2009 . Quantitative analysis suggested majority of eye have more than one mechanism underlying angle closure including pupillary block and plateau iris configuration (Shabana et al., 2012) . The other major mechanism is ciliary block due to a combination of resistance between ciliary process and lens equator (Chandler et al., 1968; Weiss and Shaffer, 1972; Shaffer, 1973, Shaffer and Hoskins 1978; Luntz and Rosenblatt, 1987) . With ageing the distance between lens equator and ciliary body decreases as lens grows. The ciliolenticular gap reducing will cause ciliary flow resistance increasing and hence ciliary block. Furthermore, small changes in lens position, such as lax lens zonules, and ciliary body, such as supraciliary swelling or ciliary edema (Liebmann et al., 1998; Trope et al., 1994) , may lead lens in contact with ciliary processes and worsen ciliary block. In these circumstances, the aqueous humor flow direction is more from posterior ciliary processes passing through anterior vitreous, traversing the anterior hyaloid to enter the posterior chamber between iris and lens, which creates a force to push the lens the ciliary processes anteriorly (Ng et al., 2012) (Fig. 6) .
The question remaining unanswered is why some angle closure eyes develop an acute disease while others develop a chronic disease. Earlier studies already revealed significant differences of anterior segment parameters between acute and chronic PACG (Sun et al., 1994) . Further evidence of significant biometric differences between acute and chronic PACG were reported as ultrasound biomicroscopy was used for biometric measurement of the eyes. Chronic PACG is characterized by a less-crowded anterior segment compared to the acute PACG (Marchini et al., 1998) . The pattern of chronic angle closure appears to mainly be "creeping closure" or "zipper up". Sihota et al. reported a narrower trabecular iris angle and shorter ciliary process distance in acute PACG than in chronic PACG (Sihota et al., 2005) . Acute PACG eyes show the greatest deviation from normal than chronic PACG eyes do on regards of lens thickness, ACD and corneal diameter (Sihota et al., 2000) . Compared to the fellow eyes of APAC, affected eyes have shallower ACD, more anterior lens position (Lim et al., 2006) and greater lens vault when assessed by AS-OCT , but these parameters of APAC eyes were already affected by acute attack.
Clearly, smaller ocular biometry is a risk factor for the acute primary angle closure. However, there could be other physiological factors triggering the acute attack, since not all narrow angles would have acute attacks throughout the life time of the patient, even for nanophthalmos. Pupil dilation is a common mechanism causing acute attack, which often happens in eyes in the dark or with the use of certain medicines. The angle width generally decreased with increased pupil diameters, and appositional closure could be developed when the pupil is mid dilated (Leung et al., 2007) . But Woo et al. reported that angle narrowing in the eyes in dark is not related to increased iris-lens touch and occurs promptly on pupillary dilation and is caused by a combination of iris shortening, increased iris thickness and increased iris convexity (Woo et al., 1999) . Another mechanism more recently proposed for acute PACG in anatomically predisposed eyes has been choroidal expansion causing a forward movement of the lens and iris, since the position of the plane of the iris-lens diaphragm may vary quite quickly as choroidal blood volume and aqueous production fluctuate (Phillips, 1972) (Fig. 6 ). However, there was no significant change in lens position, lens vault, relative lens position or axial length in eye with acute attacks compared to 2 weeks later, which did not demonstrate any evidence of lens movement in patients presenting with acute PACG . Thus, whether choroidal expansion was a trigger factor of acute attack remains controversial.
Dynamic behavior of the uvea
To move beyond anatomy alone, dynamic or physiologic changes in the anterior segment may play an important role. With advances of imaging techniques, the structure changes of anterior segment including the geometrics of angle, iris, cornea and lens as well as the choroid can be determined noninvasively (Arora et al., 2012) . These clinical data provide valuable information to further understand the pathogenesis of PACG and may allow the development of new and targeted strategies to manage different stages of PACG. Recently, the possible role of dynamic behavior of the uvea, including the iris and choroid, in the development of PACG requires consideration.
The dynamic processes leading to changes in iris and choroid volume could have a more significant and mechanistic effect on its surrounding structures than a mere anatomical observation (Quigley, 2009; Quigley et al., 2009) , such as changes of iris volume during mydriasis (Aptel and Denis, 2010; Quigley et al., 2009 ). Significant changes in iris volume have been observed using these imaging devices and postulated to be a major pathogenic factor for PACG (Aptel et al., 2012; Baskaran et al., 2013; Mak et al., 2013; Oyster, 2000; Quigley, 2009; Seager et al., 2014) . The iris volume increase per millimeter of pupil dilation was reported to be an independent predictor of angle narrowing in darkness (Aptel et al., 2012) . It was found that the iris cross-sectional area decreases after physiologic or pharmacologic pupil dilation regardless of anterior chamber angles, but with a smaller decrease in narrow-angle patients ). This suggests angle closure eyes lose less iris volume as the pupil enlarges, which might be explained by different fluid movement in and out of the iris stroma between angle closure glaucoma patients and normal people. However, the iris volume was found to increase significantly after pupil dilation in the narrow-angle eyes, whereas it decreased significantly in the open-angle eyes (Aptel and Denis, 2010) . Recently, our group found that the iris thickness at different part changed differently with aging. When the iris was evenly divided into 4 different regions, iris thickness at the area close to the angle seemed to get thickening with aging, while the area at the middle to pupil got thinning and the rest regions remained unchanged (Table 1, Fig. 5 ). Beside the change of iris thickness, the change of iris microvasculature could affect the iris volume as well , which is possibly in accordance with the change of choroid vessels. Hence the mechanisms involved in iris volume change as well as the consequence from the iris volume change could well be an important pathogenic factor in PACG.
The iris has some specific features relevant to fluid exchange with the aqueous humor and iris volume changes. The anterior surface of the iris is not covered with endothelium at or soon after birth, and a modification of the stroma composed of a relatively dense meshwork of melanocytes and fibroblasts with associated collagen forms the anterior surface of the iris (Freddo, 1996; Hogan et al., 1971; Tousimis and Fine, 1959; Vrabec, 1952) . This meshwork of cells does not form a continuous, impermeable sheet that overlies the anterior iris surface but allows aqueous humor to pass freely into the iris stroma (Freddo, 1996; Oyster, 2000) . However, the process of fluid and molecules exchange between blood vessels, stroma and aqueous humor has not been delineated, although it is known that the stroma of the iris is a sponge-like layer composed of an interwoven, collagenous framework in a matrix of hyaluronidase sensitive substance (Tasman and Jaeger, 2005 ). There does not appear to be any apparent diffusion barrier between the interstitial spaces of the iris and the anterior chamber. Therefore, aqueous flow, iris vasculature and ciliary body vasculature may offer different roles to keep a certain concentration gradient of each molecule in the aqueous humor. Previous studies have supported the pathway that plasma constituents might diffuse from the ciliary body stroma into the iridial stroma and, finally, into the anterior chamber (Freddo et al., 1990; Raviola and Butler, 1985) . Also, some molecules can selectively be transported through the iris endothelium (Raviola and Butler, 1985) . Therefore, the roles of the iris microvasculature, particularly its endothelium, need to be further explored. Recent studies of the iris vasculature found that the iris has a high density of microvasculature and an unusual pattern of vascular distribution. This consists of abundant relatively large vessels in the middle of the iris stroma supplying the microvasculature located in the superficial side of the stroma and pupil edge. Within a short distance, large diameter of capillary and relatively long spindle shaped endothelial cells in different orders of iris vasculature are present. All these findings suggest that the iris has high blood flow rate and a capability for nutrient and waste exchange between the blood stream and the iris stroma (Yang et al., 2015a,b,c) .
Choroidal expansion could be another important factor which influences the progression of shallow anterior chamber in eyes with PAC (Quigley et al., 2003) , as UBM and OCT have provided some insights suggesting a possible role of uvea in the pathogenesis of PACG. Approximately 15% of PACG demonstrated uveal effusion on UBM (Kumar et al., 2008) . Uveal effusion was not only observed in affected acute PACG eye (58%) but also in unaffected fellow eyes (23%) or chronic PAC eyes (9%) (Sakai et al., 2005) . Choroidal thickness changes have been studied in different types of PACS and PACG (Arora et al., 2012) as well as the fellow eye of acute PAC patients . It was observed that angle closure eyes had significantly thicker choroidal thickness than open angle eyes and normal eyes by using OCT (Arora et al., 2012; Huang et al., 2013a) . Furthermore, the sub-foveal choroid thickness was found to be significantly thicker in the fellow eyes in patients with unilateral acute PAC (APAC) compared with the eyes of normal individuals (Zhou et al., , 2014 .
Increased choroidal thickness/volume could very likely be a critical pathogenic factor although its exact role has still not been identified. It is expected that increased choroidal volume could induce significant changes in the anterior segment. Fig. 6 illustrates a proposed mechanism of choroidal volume changes induced PACG. The area of choroid is about 1000 mm 2 which is at least 7 times larger than the area of the iris. The area of iris in Asians is smaller than Caucasians (Seager et al., 2014) . Therefore, a small amount of choroidal volume changes may cause massive alterations of iris and lens because of the relatively rigid sclera and cornea and incompressible intraocular contents including large volume of the vitreous and small volume of aqueous in the posterior chamber. The iris diaphragm and lens could move forward and change their position and shape (Fig. 6 B2 and B3 ) from their initial position (Fig. 6 B1) resulting in pupil block and angle closure. Some interesting questions need to be addressed: why choroidal volume can be changed which may help us to understand the pathogenic roles in PACG. The choroid has very high blood flow rate per unit volume in the human body, with a circulation volume 10e20 times that of cerebral cortex (Bill and Sperber, 1990) . Choroidal over-perfusion may cause increased choroidal thickness. There are multiple hypotheses proposed such as synthesis of osmotically active molecules, vascular permeability, fluid flux from the anterior chamber to the choroid, movement of fluid across the RPE, and changes in the tone of non-vascular smooth muscle from experimental models (Nickla and Wallman, 2010) . Recently, we are focusing on other major control sites of the choroidal circulation. The vortex vein system is the drainage pathway for the choroidal circulation and serves an important function in the effective drainage of the exceptionally high blood flow from the choroidal circulation (Alm and Bill, 1987) . As there are only 4e6 vortex veins, a large volume of blood must be drained from many choroidal veins into each individual vortex vein. The choroid plays a vital role in sustaining the outer retina's high metabolic demands (Smith et al., 1985; Cringle, 2001, 2002) . In addition to the choroidal outflow, the vortex vein system also drains the anterior portion of the eye. A high volume of blood flows through numerous choroidal veins before converging into a larger, sometimes slightly dilated vessel called an ampulla, before entering the sclera to exit through a vortex vein (Hogan et al., 1971; Kaufman and Alm, 2003; Potter et al., 1984) . The entire drainage pathway from the choroid to the vortex vein is defined as the vortex vein system. The flow patterns and hemodynamic forces could be significantly non-uniform in the different regions of the geometrically complex vortex vein system. Functionally, the vortex vein system has a role in maintaining an optimal choroidal blood volume which is exposed to the positive extruding pressure within the eye as well as an abrupt drop in extravascular pressure in the region where the draining vessels leave the eye and enter the orbit. The vortex vein system must also cope with passing through tissues of different rigidity and significant pressure gradient as it transverses from the intraocular to the extraocular compartments. However, little is known about how the vortex vein system works under such complex situations in both physiological and pathological condition. The vortex vein system endothelium had not previously been studied in detail, nor were the endothelial phenotypes known at specific sites within the vortex vein system Yu et al., 2013 , 2014a , Yu et al., 2014b . We studied the endothelial intracellular cytoskeleton proteins, cell shape, and nuclei position, along with smooth muscle cell distribution in different regions of the vortex vein system in human donor eyes . The different regions studied were the choroidal veins, pre-ampulla, ampulla, post-ampulla, scleral entrance, intra-scleral channel, scleral exit and extra-scleral vortex vein. The endothelium and smooth muscle cells in the vessel wall were studied for f-actin and nuclei distribution, and the morphology of the cells. Remarkable regional differences of endothelial phenotype and smooth muscle cells distribution has been demonstrated in the vortex vein system Yu et al., 2013) suggesting that distinct hemodynamic changes occur and are very likely to be a control site for the choroidal circulation. In addition, there is rich innervation in the choroid and vortex vein system. Given the incidence of venous pathology is about ten times higher than arterial disease. It is important to study the very significant but undervalued vortex vein system of the eye. We need to develop clinical assays to evaluate the vortex vein system and determine the role in choroidal thickness changes and PACG.
Where we will be going
In respect of the pathogenic mechanism of PACG, there are still many phenomena we are not able to explain. We don't know why some people with narrow angle morphology develop PAS and others not. We are not able to determine which patients with shallow chamber and narrow angle will later develop the acute attack. Given each PACG patient has bilaterally crowded anterior segment anatomy, either pupillary block or non-pupillary block exist, and choroidal expansion does play a role, but why most acute attacks occur unilaterally is not known. Sometimes the acute attack could occur on one eye shortly after the other eye, but rarely occurs on both eyes simultaneously, except when the cause is iatrogenic medicine, such as mydriatic eye drops. Furthermore, emotion upset or stress is more often just before acute attack of PACG for many patients clinically. Then what is the mechanism behind that? How could psychological status possibly affect the development of PACG, seeing that anxiety and depression more commonly exist in glaucoma patients than in the general population? Lim et al., 2016) . It was suggested by literature that psychophysiological stress may play a part in the precipitation of acute PACG because IOP can be affected by the emotional state (Shily, 1987) . We might need to consider PACG as partly a systemic disease instead of only looking at the eyeballs in future studies.
Genetics of PACG
The heritability of narrow angle was reported as high as 60% and siblings of PACG patients have been estimated to be at 7 times more likely to have narrow angles than the general population (Amerasinghe et al., 2011). Although family history was found to be a consistent risk factor, attempts at fitting the inheritance into a certain genetic pattern did not succeed convincingly (Lowe, 1972) . These facts support that PACG is a complex heterogeneous disease. The molecular mechanisms leading to PACG are poorly understood. Recently, Vithana et al. conducted a genome wide association study (GWAS) to determine the genetic variants underlying susceptibility to PACG (Vithana et al., 2012) . The study found a genome-wide significant association between PACG and three genetic markers: rs11024102 in PLEKHA7, rs3753841 in COL11A1, and rs1015213 located between PCMTD1 and ST18 on Chromosome 8q. The contribution of the two single nucleotide polymorphisms (SNPs) in PLEKHA7 and COL11A1 were confirmed in a large PACG cohort in China and patients from Australia and Nepal (Awadalla et al., 2013) . PLEKHA7 (pleckstin homology domaincontaining family A member 7) located on Chromosome 11, is an adherens junction protein, which was found to be expressed within PACG-related structures (iris ciliary body, and choroid) and bloodeaqueous barrier (BAB) structures (posterior iris epithelium, nonpigmented ciliary epithelium, iris and ciliary body microvasculature) . COL11A1 encodes one of the two alpha chains of type XI collagen. Both COL11A1 and PLEKHA7 were shown to confer higher risk for PACG with acute attacks rather than chronic PACG , although the three genetic susceptibility loci did not found to underlie any major phenotypic diversity in terms of disease severity of progression . More recently, rs1401999 within ABCC5 (ATP binding cassette subfamily C member 5) was found to contribute to the normal variation of ACD, a quantitative trait of anatomical risk factor for PACG, through a GWAS. Importantly, the association of rs1401999 was PACG was demonstrated as well, by using casecontrol cohorts from multiple populations across Asia . In addition, SNPs on other candidate genes, including HGF (hepatocyte growth factor) (Awadalla et al., 2013) , HSP70 (heat-shock protein 70) (Ayub et al., 2010) , MFRP (membrane type frizzled related protein) (Wang et al., 2008) , MMP9 (matrix metalloproteinase-9) (Wang et al., 2008) , and eNOS (endothelial nitric oxide synthase) (Ayub et al., 2010) , were found to be genetic biomarkers for PACG as well. However, they have not yet been consistently replicated across different population, their contribution to pathogenesis of PACG remained to be confirmed (Shastry, 2013; Rong et al., 2016; Chen et al., 2016) . Recently, Khor et al. observed significant evidence of disease association at five new genetic loci, including EPDR1 (ependymin related 1) rs3816415, CHAT (choline O-acetyltransferase) rs1258267, GLIS3 (GLIS family zinc finger 3) rs736893, FERMT2 (fermitin family member 2) rs7494379, and DPM2-FAM102A (dolichyl-phosphate mannosyltransferase subunit 2, regulatory-family with sequence similarity 102 member A) rs3739821, upon meta-analysis of patients from 24 countries across Asia, Australia, Europe, North America, and South America (Khor et al., 2016) .
Nevertheless, the detailed pathogenic function of these genes in PACG was still unknown. The clinical presentation of PACG varied and the occurrence of PACG can by influenced by mood, weather, living habits and other environmental factors, which suggest PACG is a genetically complex disease. What we don't know is whether these associated genes are the real causal genes and how they could cause PACG to develop. Future functional studies will aim to validate the role of PLEKHA7 and COL11A1 in PACG pathogenesis.
Clinical characteristics and diagnosis

Natural course
According to the clinical presentation and progress of the disease, Ji and colleagues firstly put forward a staging method of acute PACG (Ji et al., 1966) , which has been widely accepted and applied in the clinical diagnosis and treatment in China. The staging system was as follows (Fig. 7 Different from acute PACG, chronic PACG is a gradual, often clinically silent, closure of the angle resulting in increased IOP and eventual glaucomatous optic nerve damage. The chronic PACG natural course was more like that of POAG. Ocular anatomic differences exist between acute and chronic PACG cases. The acute cases have a less deep anterior chamber, thicker lens, shorter axis and more narrow entrance of chamber angle than those of the chronic cases. Moreover, acute cases are more common for females and chronic cases are more common for males (Sun et al., 1994) .
What we want to know
Even though most of the acute PACG patients have typical presentation, however, part of the cases shows atypical manifestations. Some of the chronic PACG patients have acute attack when they suffered emotional stimuli or other induced factors. So, the clinical course of PACG is multiple and complicated, it is not reliable to judge it only based on the clinical presentations. Furthermore, the extent of the closed angle is an index for us to evaluate the state of the illness, but patients with the same range of closed angle might have different IOP levels and manifestations. Are there different patterns of angle closure in acute and chronic PACG? The relationship between closed angle and clinical presentations need in depth studies and new reliable indexes need to be investigated.
Angle assessment and its innovation
Gonioscopy remains the most important diagnostic method for assessing the presence of angle closure. With gonioscopy examination, pupillary block could be manifested as iris bowing into a convex shape, appositional contact with the trabecular meshwork, and eventually peripheral anterior synechiae (PAS). Indentation gonioscopy in particular is an essential technique for assessing appositional angle closure (Fig. 8) and PAS (Fig. 1) . The static angle should be examined first, and then do dynamic indentation gonioscopy, which could help to determine the extent of PAS and differentiate plateau iris configuration from pupillary block.
Notably, gonioscopy is highly subjective, and the findings may vary with the amount of light or mechanical compression of the eye used during the examination. Quantitative studies of the anterior segment structures therein could provide objective measurements, including UBM and anterior segment OCT (AS-OCT) (Dorairaj et al., 2012) . With tissue resolution of approximately 50 mm and penetration depth of 5 mm, UBM is capable of imaging the posterior chamber and ciliary body, which could not be examined by gonioscopy. However, it is difficult to differentiate appositional angle closure from PAS using just UBM and also patients require examination in the supine position. AS-OCT is a noncontact optical signal acquisition and processing device that provides magnified, high-resolution cross-sectional images of ocular tissues. Since AS-OCT can visualize the entire anterior chamber, all the essential parameters for detection of angle closure can be examined in a single scan. Slit lamp OCT (SL-OCT) has the potential to provide valuable quantitative and spatial information regarding dynamic changes of the angle configuration (Leung et al., 2008) . Using OCT, details of anterior chamber drainage angle including Schlemm's canal and trabecular meshwork could be visualized and analyzed (Asrani et al., 2008; Hong et al., 2013 Hong et al., , 2014 . Recently, swept-source OCT (SS-OCT) is specifically designed for anterior segment imaging. It allows 360-degree imaging of the angle and iris. Both the scleral spur and the Schwalbe's line can be identified. Using this SS-OCT, the trabecular meshwork width , iridocorneal angle width (Tun et al., 2014) , iris volume Tun et al., 2014) and PAS (Lai et al., 2013) could be evaluated. But to date, none of the above imaging methods provides sufficient information about the anterior chamber angle anatomy to be considered a substitute for gonioscopy . At present, new generation of imaging devices need to be explored for more convenient and comprehensive methods, not only morphology but also structural mechanics about angle closure. It will greatly improve the accuracy and efficiency of angle examinations in epidemiological and clinical studies.
Optic nerve damage
Glaucomatous optic neuropathy is the characteristic of POAG. However, the patterns of optic nerve damage are different in PACG. At the early stage of PACG such as preclinical stage or intermittent stage or PACS and PAC, there is no detectable optic nerve damage. Even after episodes of acute attack, the eyeball might present a pale disc with diffuse field depression instead of a cupping disc (Douglas et al., 1975) . The possible reason is that acute attack is equivalent to the ischemia of optic disc caused by a very high IOP. As the disease progresses, eyes with PACG tends to have a lower PSD (pattern standard deviation) with a more diffuse field loss, while POAG eyes are more likely to have localized defect in the superior Hemifield (Fig. 9) (Gazzard et al., 2002) . It is in agreement with findings that inferotemporal rim loss is more common in POAG eyes (Nouri-Mahdavi et al., 2011) . There is greater asymmetry of visual field loss between eyes, as measured by AGIS scores and mean defect, in PACG than in POAG (Wang et al., 2008) . At the late stage of PACG, the characteristic of visual field defect also differs from POAG. PACG had more severe defect of the central visual field, while the damage of superior and the inferior hemifield in PACG are similar to POAG. (Han et al., 2009 ) The eyes with a central visual field island tend to have the central retinal vessel trunk in the temporal optic disc region (Huang et al., 2013b) . Using OCT angiography, the peripapillary microvasculature could be detected, and the data shows that uniform reduction of vessel density is found in PACG while a regional reduction is usually found in POAG (Wang et al., , 2016 . Chronic PACG is also different from acute PACG. The abnormally shaped rim width (alteration of ISN'T rule), bared circumlunar vessel, vessel bayonetting, rim width narrower than the temporal sector, and zone beta (nasal and super temporal sectors) were detected more frequently in chronic PACG (Uhm et al., 2005) . Further studies are needed to investigate whether all these structural changes have corresponding characteristic changes of visual function between PACG and POAG.
Differential diagnosis
In some cases, PACG should be differentiated from other ocular/ systemic diseases. During acute attack of PACG, pain, hyperemia and cellulose-like exudation is found in some cases, while cellulose-like exudation is commonly found in iridocyclitis, then it could be misdiagnosed as iridocyclitis. However, the following points could help to distinguish: the normal depth anterior chamber and normal IOP could not be found in PACG but in iridocyclitis. Many patients suffer headache, nausea and vomiting during acute attack of PACG, if ignored the symptoms of the eyes, they would be misdiagnosed as migraine, cerebrovascular accident, or gastroenteritis and so on. After antispasmodics such as atropine were misused, the situation would become more dangerous.
Angle closure glaucoma resulting from the uveitis such as VogtKoyanagi-Harada (VKH) or some kinds of medicine usage should also be noted. They all show acute onset, vision loss, shallow anterior chamber and headache. Uveal effusion could cause swollen of ciliary body and ciliary detachment, which might cause anterior rotation of ciliary body, anterior movement of lens and then result in secondary pupil block and angle closure. Usually, VKH affects both eyes, presents a small pupil and typical fundus changes, and sometimes is accompanied by systemic symptoms such as tinnitus or hair loss. Generally, PACG would not have acute attack of both eyes at the same time, while secondary angle closure glaucoma could affect both eyes simultaneously. And the PACG eyes have characteristic parameters such as short axial length while VKH eyes do not. On the other hand, given the causal phenomenon between uveal effusion and angle closure, it may enlighten the idea that the role of vascular dysregulation in PACG is worth paying attention to.
Controversies in PACG diagnostic criterion
To diagnose PACG with the requirement of glaucomatous optic neuropathy remains controversial. First, the current ISGEO protocol (optic disc abnormalities and visual field defect) may not be sensitive enough to detect glaucomatous optic neuropathy in PACG patients as described above (Liang et al., 2011) . Besides, quite a few patients could be present with occludable angle, PAS, and raised IOP during visits, OCT examination may already detect inferotemporal RNFL bundles thinning, but their visual field (with standard examination program) is within normal range, it will be classified as PAC according to the ISGEO protocol. But we think it should be diagnosed as early stage of chronic PACG.
Second, PACG could cause damage to the eye in addition to glaucomatous optic neuropathy. In patients suffering from serious acute attack of PACG, the optic disc may become swollen and later in chronic stage the disc may show similar signs to ischemic optic neuropathy. Simultaneously, signs of iris ischemic atrophy and glaucomflecken may arise from acute attack. It is an ophthalmic emergency and the prognosis is often poor, but it could not be classified as PACG according to the ISGEO definition. Even in very early stage of chronic PACG, appositional and synechial closed angle is causing damage to trabecular meshwork and deteriorating outflow facility. Since it is well recognized that angle closure is a fundamental pathologic process, in some recent literature, angle closure disease (Sinota, 2011; Walland and Thomas, 2011) was named in order to separate from the ISGEO definition of PACG. Recently, we investigated peripapillary retinal perfusion in eyes after an attack of acute PACG one month later by optical coherence tomography angiography (OCT-A). These eyes had a lower peripapillary retinal flow index (0.083 ± 0.012 vs. 0.093 ± 0.011; Fig. 9 . Visual field patterns of PACG and POAG. Left column: a more diffuse field loss in PACG. Right column: localized defect in the superior hemifield in POAG. P ¼ 0.001) and vessel density (79.3 ± 8.2 vs. 85.6 ± 4.9; P ¼ 0.001) than those of the fellow normal eyes, showing the damaged retinal circulation after acute attack (Fig. 10, Table 2 ). OCT-A is a sensitive way to detect vascular changes in PACG eyes. The above evidence suggests that the ISGEO definition of PACG may not be suitable in clinical practice at the present time.
Third, the mechanism of optic nerve damage caused by PACG is different from that of POAG. The typical development of PACG is angle closure, IOP elevation and then optic nerve damage. While in many POAG (including NTG), IOP could be within the normal range and vascular factors are considered to be important factors leading to typical optic neuropathy. Moreover, although both are considered to be a chronic pathologic process, studies show that the patterns of glaucomatous damage in chronic PACG are different from those in POAG (Nouri-Mahdavi et al., 2011) . Evidence suggests that the pathological changes of optic nerve head (ONH) in PACG and POAG are different. The latter one was reported to have some innate abnormality, such as laminar cribrosa defect (Tatham et al., 2014; Kimura et al., 2014) , or peripapillary vascular abnormality (Flammer et al., 2002; Jonas et al., 2015; Tobe et al., 2015) in the pathogenesis of POAG, especially NTG. Our recent study using OCT-A also showed that acute PAC eyes had lower peripapillary vessel density compared with normal eyes (56.43 ± 5.84 vs. 65.98 ± 2.03, P < 0.001), while POAG eyes had the lower vessel density in the inferior temporal quadrant in the peripapillary region (46.75 ± 11.80 vs. 59.65 ± 7.63, P < 0.001) (Fig. 10, Table 2 ). Moreover, unlike POAG, the ONH in PACG has no sign of innate abnormality before IOP elevation, and may tolerate much higher IOP. Therefore, copying the diagnostic algorithm on optic nerve damage of POAG to PACG in ISGEO protocol may be inappropriate. The further modification of current ISGEO protocol about PACG is needed before it could be adopted more as a glaucoma guideline in clinical practice.
Clinical management
Management of PACG differs considerably from that used in POAG cases because of the fundamentally different mechanisms of the two diseases . Unlike POAG, PACG to some extent is a preventable disease. Except IOP lowering, the management to protect the anterior chamber angle and keep its drainage function is unique for PACG. It is very important since the angle of PACG is original with normal drainage function. Focusing the anterior chamber angle is a principal management strategy for PACG. Choice of management is dependent on the stage of the disease. As for PACS and PAC, the aim is to modify the anterior segment configuration preventing angle closure and IOP elevation. As for PACG, the aim is to protect those yet not closed angle, and to lower the IOP to prevent the worsening of glaucomatous optic neuropathy and visual field loss.
6.1. Medical treatment 6.1.1. Reopening appositional angle closure and preventing synechial closed angle Cholinergic agonist, pilocarpine, is the first-line drug for treating PACG. It contracts the pupillary sphincter, pulling the peripheral iris away from the trabecular meshwork and therefore reopening the drainage angle. Pilocarpine is still widely used in Asian countries, as it is inexpensive and effective for patients with PACG. However, pilocarpine agents have not been shown to lower IOP in these eyes which had whole angle closed because of permanent synechial formation. In addition, frequently used pilocarpine may cause some complications like synechial miosis, ciliary muscle spasm to induce malignant glaucoma and tear the peripheral retina in some cases (Pape and Forbes, 1978; Beasley and Fraunfelder, 1979; Stocker, 1947) .
For acute attack cases, topical steroids are also important that can control the inflammation of the anterior segment, restrain the formation of PAS, and protect the structure and function of angle drainage.
Agents for IOP reduction
Agents used in POAG to reduce IOP, such as beta-adrenergic antagonists, alpha2-adrenergic agonist and carbonic anhydrase inhibitors (CAIs) by reducing aqueous production, prostaglandin analogues (PGAs) by enhancing intraocular fluid outflow, are also used in cases of PACG.
In a randomized trial (Kim et al., 2011) , the effects of brimonidine and of brimonidine/timolol fixed combination (BTFC) on the pupil and angle structures were assessed in both normal subjects and POAG patients. Results showed that brimonidine and BTFC caused miosis and widening of most of the anterior chamber angle parameters without changing the anterior chamber depth. The effects of BTFC on the angle were likely to be greater than those resulting from the pilocarpine. Another investigation showed that adrenergic alpha2 agonists inhibit the contraction of cholinergically innervated bovine ciliary muscle (Kubo and Suzuki, 1992) .
The main mechanism of PGAs for IOP reduction is increasing uveoscleral outflow (Toris et al., 1993) . However, they have no effects on the aqueous humor production (Ziai et al., 1993) . Studies have shown PGAs are effective at lowering IOP in chronic PACG Hung et al., 2000) . No correlation was found between efficacy of PAGs and the extent of synechial closed angle . A report found that even in eyes with 360 degrees of PAS, latanaprost is still effective in lowering IOP (Kook et al., 2005) . 
What new agents for PACG we need
With the miotic effects, pilocarpine can also cause ciliary muscle contraction resulting in anterior chamber shallowing, anterior movement of the lens-iris diaphragm and increasing thickness of the lens (Abramson et al., 1972; Wilkie et al., 1969) . These effects increase the risk of severe ciliary block and other side effect. The question is which miotic agents are best for PACG? The aim is to use miotic agents to pull the peripheral iris away from the trabecular meshwork by contraction of the pupillary sphincter and keep open the drainage angle. Ciliary muscle contraction should be avoided. A special subtype of miotic agents, which act only on the pupillary sphincter but not the ciliary muscle, needs to be developed even though research already goes several decades about muscarinic receptor subtypes of cholinergic receptor (Gupta et al., 1994; Gil et al., 2001; Luo et al., 2001) . Furthermore, the role of brimonidine on angle structure in PACG and the possible mechanism of PGAs effective in IOP reduction on whole closed angle are interesting topics to be further investigated.
Laser therapy 6.2.1. Laser peripheral iridotomy
Although many anatomic mechanisms may result in angle closure, virtually majority eyes with angle closure possess a component of relative pupillary block. LPI successfully eliminates the relative pupillary block component of the angle closure process.
Iridotomy can be accomplished by incisional surgery or laser. Because of the safety and effectiveness, LPI has become a preferred alternative treatment for incisional surgery. It is recommended as prophylactic treatment for all occludable angles (Schwartz et al., 1986) . It is generally accepted that LPI should be performed immediately after the termination of acute attack with medical therapy. For chronic PACG, LPI should be performed in these eyes to eliminate pupillary block and the progression of PAS. LPI is commonly used as a prophylactic treatment, but evidence is lacking as to its efficacy in preventing all PACG. A study of Asian eyes showed that a high proportion (58.1%) of eyes with APAC developed increased IOP on long-term follow-up after resolution of the acute attack, despite the presence of a patent LPI (Aung et al., 2001) (Fig. 11) .
Argon laser peripheral iridoplasty
For patients undergoing acute attacks of angle closure, Argon laser peripheral iridoplasty (ALPI) has been used as initial treatment to open the drainage angle prior to LPI and can achieve rapid efficacy (Lam et al., 1998) . Other indications of ALPI include plateau iris configuration or in eyes with an enlarged or intumescent lens, the angle remains appositionally closed or occludable following LPI. However, the clinical efficacy of ALPI in these indications remains to be determined. Recently, some randomized, controlled clinical trials explored the efficacy and safety of ALPI in the treatment of eyes with synechial PAC or PACG. One research found that there were no significant difference in IOP, medications, need for surgery, or visual function between groups of ALPI with/without LPI at the 1-year visit (Sun et al., 2010) . Narayanaswamy et al. compared the effectiveness of ALPI with PGA therapy (Travoprost 0.004%) in PAC or PACG, and found ALPI was associated with higher failure rates and lower IOP reduction compared with PGA therapy (Narayanaswamy et al., 2016) . These results suggest that ALPI might have little role in PAC/PACG eyes.
What we need to think about LPI/ALPI
Some authors suggest that all patients with chronic PACG should receive LPI as the initial treatment (Ritch, 1981; Quigley, 1981; Gieser and Wilensky, 1984) . But for some advanced stage eyes with whole or almost whole angle closed, the possibility of reducing IOP after LPI is remote and the IOP spike after LPI may cause further harm to the already fragile optic nerve. For these patients the question is whether or not it is necessary to select LPI as the initial treatment? Further studies are mandated since there is little evidence regarding this topic. For some cases with thicker and darker iris, LPI can induce severe inflammation and iris pigment spread to cause a significant IOP spike, even resulting in corneal endothelial decompensation . Iridotomy by laser or incisional surgery should be selected according to the iris characteristic by UBM. So incisional surgical iridotomy may be more suited for these eyes because it excises a small piece of peripheral iris which is then taken out of the eyeball.
A study on angle-closure mechanism in Chinese PACG patients found that 38.1% patients had pure pupillary block (Wang et al., 2000) . Another study which compared anterior segment parameters in Chinese and Japanese subjects with angle closure, found that comparing with Chinese, Japanese angle-closure eyes have smaller and more crowded anterior segment with thicker lenses . These findings support the notion that non-pupil block mechanisms may play more of a role in the pathogenesis of angle closure in some Asian populations. Therefore, we need to further address whether ALPI with LPI should be performed as the standard treatment of Asian PACG patients?
Laser parameters used for PACS treatments need to be quantitatively studied. We still don't have clear or quantitative indications of optimized laser treatment for PACS. In fact, there are suspected of excessive laser treatment for PACS (He et al., 2006a,b; Nolan et al., 2000) .
Selective laser trabeculoplasty (SLT)
SLT is an effective method of lowing IOP for POAG and ocular hypertension. Its efficacy in the treatment of PACG or PAC was explored in recent years. In a case control study (Ali Aljasim et al., 2016) , effectiveness of SLT in PAC/PACG (with an opening of the angle for at least 180 ) was compared with POAG. The results showed that the safety and efficacy of SLT was equivalent in PAC/ PACG and POAG. In another randomized clinical trial (Narayanaswamy et al., 2015) , the IOP-lowering efficacy of SLT was assessed with that of prostaglandin analog (PGA; travoprost, 0.004%) in PAC/PACG eyes, found that there were no differences between the SLT and PGA groups in the absolute value or in the percentage of IOP reduction. These findings support the notion that SLT could be a therapeutic option in eyes with angle closure, but the overall long-term therapeutic effectiveness needs further evaluation.
Surgical management
The mainstay of PACG therapy is largely surgical. Incisional surgery for PACG is typically required when laser and/or medical therapy fail to control the IOP. There is at present no consensus on the best approach to the surgical management of PACG. Once LPI is performed and IOP is still not optimally controlled, the surgical options for PACG are diverse. These include trabeculectomy, angle widening procedures, such as lens extraction with/without goniosynechialysis, and combined cataract with filtering surgery.
6.3.1. Shallow anterior chamber after filtering surgery Trabeculectomy, which is the most common procedure of glaucoma surgery, is also effective for ACG (Salmon, 1993) . Trabeculectomy has been shown to have an overall success rate of 68% in terms of IOP control (Sharif and Selvarajah, 1997) .
The biggest risk of the filtering surgery for PACG was the shallow or flat anterior chamber post-operation. Flat anterior chamber with hypertension is malignant glaucoma, which is special complication with PACG surgery. Even though we had management strategy like ciliary muscle spasmolysis (e.g. Atropine drops), vitreous tapping, laser cutting posterior capsule and anterior vitreous limiting membrane in intraocular lens (IOL) eyes, lens extraction, and vitrectomy, some eyes still had tragic results. For these cases, modified or innovated management will be developing to solve this special problem based on the mechanism of malignant glaucoma from PACG.
Flat anterior chamber with hypotony is often accompanied by choroidal effusions or detachment in PACG. By UBM, ciliary detachment often observed in PACG, especially in the eyes of acute PACG. Ciliary-Choroidal detachment due to serous effusions in the supra-cyclochoroidal space is a frequent occurrence after trabeculectomy, especially in association with a sudden decrease of IOP. However, with the use of adjunctive antimetabolites during trabeculectomy, prolonged hypotony may lead to prolonged or persistent ciliary-choroidal detachment (WuDuun et al., 2005) . Severe ciliary-choroidal detachments cause a shallow anterior chamber, retinal detachment, complicated cataract, even choroidal hemorrhage. According to the recognition of ciliary-choroidal effusions and the potential joint space of ciliary-choroid, trabeculectomy combined with prophylactic sclerotomy is developed by the author to control IOP in glaucoma patients with high risk of surgical complications and provides a promising intervention to prevent intra and postoperative severe ciliary-choroidal effusion. The process of operation: followed by a scleral flap 4 mm by 5 mm with half of the full scleral thickness, then a 3 mm incision was made through the full thickness of the sclera, across the posterior margin of the scleral bed, and perpendicular to the limbus until the ciliary-choroid underneath was exposed. The anterior half of the scleral incision (about 1.5 mm) was covered by the scleral flap and the posterior half was not covered (Fig. 12) . The cutting edges of the scleral incision were cauterized to keep it open as long as possible postoperatively. After the sclerotomy, a standard trabeculectomy was performed (unpublished data).
A 3 mm incision sclerotomy (black arrow) was made through the full thickness of the sclera across the posterior margin of the scleral bed perpendicular to the limbus until the ciliary-choroid underneath was exposed. The anterior half of the scleral incision (about 1.5 mm) was covered by scleral flap and the posterior half was not covered.
The sclerotomy across the boundary of the posterior scleral bed worked as a drainage passage from supra-cyclochoroidal space to the subconjuntival space and could drain ciliary-choroidal effusion, even hemorrhage outside the globe at the earliest stage without resistance of the scleral flap. This immediate drainage lowers the pressure of the supra-cyclochoroidal space which reduces or avoids severely massive ciliary-choroidal effusion and explosive choroidal haemorrhage. Trabeculectomy combined with prophylactic anterior sclerotomy within scleral bed should be a safe and effective technique in high risk eyes of PACG.
Lens extraction with/without goniosynechialysis
A thicker lens is considered to play an essential role in the pathogenesis of angle closure by causing a decrease ACD, resulting in angle crowding (George et al., 2003) . Lens extraction offers yet another approach to treating angle closure. Lens removal is associated with deepening of the anterior chamber and widening of the angle (Hayashi et al., 2000) . Removal of the lens may also decrease the possibility of recurrent angle closure (Roberts et al., 2000) . There is increasing evidence regarding the effectiveness of lens extraction for PACG (Tham et al., 2009) . A recent RCT research showed that clear-lens extraction showed greater efficacy and was more cost-effective than laser peripheral iridotomy, and should be considered as an option for first-line treatment (Azuara-Blanco et al., 2016) .
Combining goniosynechialysis with lens extraction has the advantages of angle widening and IOP-lowering effect (Shao et al., 2015) . However, irreversible damage to the trabecular meshwork may occur in areas of synechial closure. This may explain why goniosynechialysis appeared to be less effective in angle closure of longer duration. In order to be effective, it must be performed before there is irreversible histological change in the trabecular meshwork. But how can we decide which duration of angle closure/ closed is better indication for goniosynechialysis? This is a question remaining to be answered since there are no function evaluated methods for angle drainage at present, although we can speculate it from the angle morphology by gonioscopy, AS-OCT or UBM.
Conclusion and future directions
PACG, a common cause of blindness, develops due to angle closure. Though it is estimated that the rate of bilateral blindness in PACG remains high (22.6% in 23.36 million patients) in 2020 (Quigley and Broman, 2006) , treatments to open the angle are proving their effectiveness. PACG is a more IOP-dependent disease compared with POAG. While there is now evidence available to guide us in setting target IOPs when treating POAG, there is no consensus on what IOP levels are required to prevent progression of glaucomatous optic neuropathy in PACG. Moreover, given the cost effective management and diverse health care systems in different countries, future studies will need to identify which kind of angles and/or persons are more likely to benefit from the prophylactic treatment.
Our understanding of the pathogenesis of PACG has been improved in recent years. Scientific progress is propelled by improved observation technology. Astonishing improvements in medical imaging allow us to reveal the untold information of PACS and PACG. Numerous imaging techniques such as UBM and AS-OCT and OCT-A have been widely used in clinical examination of different stages of PACG patients to quantitatively determine the relationship between the angle, iris, lens and choroid geographically and dynamically. These clinical studies will help us to further exploit knowledge of pathogenesis of PACG, challenge our traditional concepts and stimulate further basic scientific research. For example, we have demonstrated the volume changes of the choroid and iris in PACG. Why do such volume changes occur and how to modulate these changes? To address these questions, we have to further study on endothelium, microvasculature, extracellular matrix and innervation within the uveal tissues. It is expected that the answers to these questions will help us to improve clinical management of PACG.
PACG also is a typical psychosomatic disease. Currently what we know about PACG is just within the eyeball. With the development of functional magnetic resonance imaging and cognitive approaches, future research may investigate the entire visual pathway and brain function, the relationship among psychological status, neurotransmitter, and neural circuits, and their roles in the pathogenic mechanism on occurrence and progression of PACG (Zhang et al., 2016) (Fig. 13) . IOP regulation system is another important field, which may be closely related with the onset and relief of attacks in PACG. Given the dopamine activity in the central nervous system, recent study on dopamine D3 receptor modulating intraocular pressure is promising (Leggio et al., 2016) . Hopefully, new treatment strategies like adjusting the psychological status and balancing the sympathetic-parasympathetic nerve, and innovative medicines based on these researches may develop to improve the prognosis of PACG.
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